HIGHLIGHTS
- who: Christiane Palm and colleagues from the Pathologie Institute Enge, Zurich, Switzerland Faculty of Medicine, University of Zurich, Zurich, Switzerland have published the paper: Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors, in the Journal: Diagnostics 2023, 13, 168. of /2023/
- what: The preliminary cohort consisted of 495 primary carcinomas and the study cohort included 67 primary carcinomas and 30 metastatic deposits which were evaluated for status by immunohistochemistry (IHC) and in situ hybridization (ISH). Since both IHC and ISH supplement each other in the diagnostic process . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.